-
-
-
-
-
-
-
Leap Therapeutics Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting
-
-
-
-
-
-
-
Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

